NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone

Go back to NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone
(NASDAQ: NTHI) Delayed: 2.94 +0.17 (6.14%)
Previous Close $2.77    52 Week High $ 
Open $2.80    52 Week Low $ 
Day High $2.96    P/E N/A 
Day Low $2.75    EPS $ 
Volume 62,916